Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2009 / Cilt: 43 - Sayı: 3

Narrowband ultraviolet B treatment in skin diseases beyond vitiligo, psoriasis and mycosis fungoides

Vitiligo, psoriasis ve mikozis fungoides dışı deri hastalıklarında dar-bant ultraviyole B tedavisi

Pages
83–88
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The effects of narrowband ultraviolet B in atopic dermatitis, pityriasis lichenoides, lichen planus, pruritus, chronic urticaria, symptomatic dermographism and polymorphic light eruption are discussed here in light of the literature data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Narrowband ultraviolet B, with its nonspecific immunmodulatuar actions, is a potential treatment alternative in many skin diseases.
📊
Key Findings & Data:Various studies have shown its effects in psoriasis and vitiligo, treatment protocols have been developed especially for psoriasis.
💡
Conclusion & Impact:The effects of narrowband ultraviolet B in atopic dermatitis, pityriasis lichenoides, lichen planus, pruritus, chronic urticaria, symptomatic dermographism and polymorphic light eruption are discussed here in light of the literature data.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Narrowband ultraviolet B, with its nonspecific immunmodulatuar actions, is a potential treatment alternative in many skin diseases. Various studies have shown its effects in psoriasis and vitiligo, treatment protocols have been developed especially for psoriasis. Apart from these, narrowband ultraviolet B is used as first-line therapy in skin conditions that are common in clinical practice. However, its efficacies in such diseases are not very well-known. The effects of narrowband ultraviolet B in atopic dermatitis, pityriasis lichenoides, lichen planus, pruritus, chronic urticaria, symptomatic dermographism and polymorphic light eruption are discussed here in light of the literature data.

Özet

Dar bant ultraviyole B, nonspesifik immunmodulatuar etkileri ile pek çok deri hastalığı için potansiyel bir tedavi seçeneğidir. Psoriasis ve vitiligodaki etkileri çok sayıda çalışmada gösterilmiş, özellikle psoriasiste dar bant ultraviyole B tedavi protokolleri geliştirilmiştir. Ayrıca, pratikte sık karşılaşılan birçok hastalıkların tedavisinde de ilk basamaklarda tercih edilen bir yöntem haline gelmiştir. Ancak, bu hastalıklardaki etkinliği çok iyi bilinmemektedir. Burada, atopik dermatit, pitriyazis likenoides, liken planus, kaşıntı, kronik ürtiker, semptomatik dermografizm ve polimorf ışık erüpsiyonunda dar bant ultraviyole B’nin etkinliği, literatür bilgileri ışığında tartışılacaktır.

🔖

Cite This Article

SEÇKİN, D., YILMAZ, E. (2022). Narrowband ultraviolet B treatment in skin diseases beyond vitiligo, psoriasis and mycosis fungoides. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 43 - Sayı: 3, 83–88. https://ajindex.com/articles/622086

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ibbotson SH, Bilsland D, Cox NH, Dawe RS, Diffey B, Edwards C, Farr PM, Ferguson J, Hart G, Hawk J, Lloyd J, Martin C, Moseley H, McKenna K, Rhodes LE, Taylor DK: An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004;151:283-97
  2. Gambichler T: Management of atopic dermatitis using photo(chemo)therapy. Arch Dermatol Res 2009;301:197-203
  3. George SA, Bilsland DJ, Johnson BE, Ferguson J: Narrow-band (TL-01) UVB air conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49-56
  4. Collins P, Ferguson J: Narrowband (TL-01) UVB air-conditioned phototherapy for atopic eczema in children. Br J Dermatol 1995;133:653-4
  5. Hudson-Peacock MJ, Diffey BL, Farr PM: Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996;135:332
  6. Krutmann J: Phototherapy for atopic dermatitis. Clin Exp Dermatol 2000;25:552-8
  7. Silva SH, Guedes AC, Gontijo B, Ramos AM, Carmo LS, Farias LM, Nicoli JR: Inşuence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J Eur Acad Dermatol Venereol 2006;20:1114-20
  8. Gambichler T, Skrygan M, Tomi NS, Altmeyer P, Kreuter A: Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy. Br J Dermatol 2006;155:1275-8
  9. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM: Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001;357:2012-6
  10. Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A: Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000;142:39-43
  11. Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P: Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003;139:223-4
  12. Majoie IML, Oldhoff JM, van Weelden H, Laaper-Ertmann M, Bousema MT, Sigurdsson V, Knol EF, Bruijnzeel-Koomen CAF, de Bruin-Weller MS: Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2009;60:77-84
  13. Gambichler T, Othlinghaus N, Tomi NS, Holland-Letz T, Boms S, Skrygan M, Altmeyer P, Kreuter A: Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized cr